8,71 $
4,06 %
Nasdaq, Fr, 01.03.2024
ISIN
US82835W1080
Symbol
SBTX
Berichte
Sektor
Industrie

Silverback Therapeutics Aktie News

Positiv
24/7 Wall Street
mehr als ein Jahr alt
Fintel reports that Tanimoto Sarina has filed a 13D form with the SEC disclosing ownership of 6,265,170 shares of Silverback Therapeutics Inc (SBTX).
Neutral
PRNewsWire
mehr als ein Jahr alt
NEW ORLEANS , Aug. 10, 2022 /PRNewswire/ -- Former Attorney General of Louisiana Charles C. Foti, Jr., Esq.
Neutral
PRNewsWire
mehr als ein Jahr alt
NEW YORK , July 27, 2022 /PRNewswire/ -- Juan Monteverde , founder and managing partner of the class action firm Monteverde & Associates PC (the "M&A Class Action Firm"), a national securities firm rated Top 50 in the 2018-2021 ISS Securities Class Action Services Report and headquartered at the Empire State Building in New York City, is investigating Silverback Therapeutics, Inc. (SBTX), relat...
Neutral
PRNewsWire
mehr als ein Jahr alt
NEW YORK , July 22, 2022 /PRNewswire/ -- Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Silverback Therapeutics, Inc. ("Silverback" or the "Company") (NASDAQ: SBTX), in connection with the Company's proposed merger with ARS Pharmaceuticals, Inc. ("ARS").  Under the terms of the merger agreement, assuming that the Company's...
Positiv
GeekWire
mehr als ein Jahr alt
Less than two years after its IPO and months after shutting down its once-promising oncology program, Seattle-based Silverback Therapeutics will merge with another biotech company, San-Diego based ARS Pharmaceuticals.
Negativ
GeekWire
fast 2 Jahre alt
Silverback Therapeutics will lay off 27% of its workforce and close its oncology program, the Seattle company announced Thursday in its fourth quarter earnings report.
Neutral
PRNewsWire
etwa 2 Jahre alt
NEW YORK, Jan. 3, 2022 /PRNewswire/ -- The following statement is being issued by Levi & Korsinsky, LLP: To: All persons and entities that purchased or otherwise acquired: (a) Silverback Therapeutics, Inc. ("Silverback" or the "Company") (NASDAQ: SBTX) common stock pursuant and/or traceable to documents issued in connection with the Company's initial public offering conducted on or about Decemb...
Neutral
PRNewsWire
etwa 2 Jahre alt
LOS ANGELES, Dec. 31, 2021 /PRNewswire/ --  The Schall Law Firm , a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Silverback Therapeutics, Inc. ("Silverback" or "the Company") (NASDAQ: SBTX) for violations of the federal securities laws. Investors who purchased the Company's shares pursuant and/or traceable to the Company's initial public of...

Kostenlos registrieren

aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.

Die Apple Aktie im Überblick mit Charts, aktuellen Kennzahlen, Nachrichten und Aktienanalysen.
Die besten Dividenden-Aktien in der Dividenden-Topscorer-Liste.
Aktienanalysen der besten Aktien weltweit.
Jetzt Vermögen aufbauen